3-Bromo-5-(trifluoromethyl)benzene-1,2-diamine

Catalog No.: 
ACGZDF274
CAS No.: 
113170-72-2
Molecular Formula: 
C7H6BrF3N2
Molecular Weight: 
255.04
3-Bromo-5-(trifluoromethyl)benzene-1,2-diamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$111.00In stockInquiry
100g97%$404.00In stockInquiry
500g97%$1959.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-(trifluoromethyl)benzene-1,2-diamine
IUPAC Name3-bromo-5-(trifluoromethyl)benzene-1,2-diamine
MDL No.MFCD00042484
Molecular FormulaC7H6BrF3N2
Molecular Weight255.04
SMILESNC1=CC(C(F)(F)F)=CC(Br)=C1N
InChI KeyOVGAPUVMLZWQQF-UHFFFAOYSA-N
Synonym113170-72-2 | 3-bromo-5-(trifluoromethyl)benzene-1,2-diamine | 3-Bromo-4,5-diaminobenzotrifluoride | 3-Bromo-5-trifluoromethyl-1,2-phenylenediamine | C7H6BrF3N2 | 1,2-diamino-3-bromo-5-(trifluoromethyl)benzene | MFCD00042484 | 1,2-Diamino-3-bromo-5-trifluoromethyl benz
CAS No.113170-72-2
PubChem CID735785

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGZDF274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMQKI974 route compound structure diagram
    ACMQKI974113170-71-1In Stock
  2. Then
  3. ACGZDF274 route product structure diagram
    ACGZDF274113170-72-2In Stock
Inquiry

2. ACGZDF274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZDF274 route product structure diagram
    ACGZDF274113170-72-2In Stock
Inquiry

3. ACGZDF274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZDF274 route product structure diagram
    ACGZDF274113170-72-2In Stock
Inquiry

Comments (0)